Table 2 The relationship between PTPRH expression and clinical characteristics of NSCLC patients
Clinical characteristics | N | PTPRH expression level (mean ± standard deviation) | P value |
|---|---|---|---|
Age (year) | 0.320 | ||
≥ 60 | 41 | 6.64 ± 2.867 | |
< 60 | 39 | 7.27 ± 2.737 | |
Gender | 0.670 | ||
male | 45 | 6.83 ± 2.828 | |
female | 35 | 7.20 ± 2.807 | |
Tumor diameter (cm) | 0.004** | ||
≤ 3 | 54 | 6.21 ± 2.274 | |
> 3 | 26 | 7.94 ± 2.7363 | |
Clinical stage | 0.003** | ||
I–II | 43 | 5.28 ± 2.1310 | |
III–IV | 37 | 6.97 ± 2.8042 |